• Fund Type: Open-End Fund
  • Objective: Health Care Sector
  • Asset Class: Equity
  • Geographic Focus: Global

CI Global Health Sciences Corporate Class

+ Add to Watchlist

UNISHSCI:CN

50.87 CAD 0.39 0.77%

As of 07:59:30 ET on 08/26/2014.

Snapshot for CI Global Health Sciences Corporate Class (UNISHSCI)

Year To Date: +14.31% 3-Month: +7.00% 3-Year: +36.09% 52-Week Range: 38.88 - 55.19
1-Month: +5.65% 1-Year: +29.49% 5-Year: +21.36% Beta vs CXBT: 0.73

Mutual Fund Chart for UNISHSCI

No chart data available.
  • UNISHSCI:CN 50.87
  • 1M
  • 1Y
Interactive UNISHSCI Chart

Previous Close

No chart data available.
Interactive Chart
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Fund Profile & Information for UNISHSCI

CI Global Health Sciences Corporate Class is an open-end fund incorporated in Canada. The Fund seeks to obtain maximum long-term capital growth. The Fund invests primarily in equity and equity-related securities of companies around the world that specialize in the health care or medical industry.

Inception Date: 07-23-1996 Telephone: 1-800-268-9374
Managers: ANDREW WAIGHT
Web Site: www.ci.com

Fundamentals for UNISHSCI

NAV (on 2014-08-26) 50.87
Assets (M) (on 2014-05-30) 314.91
Fund Leveraged N
Minimum Investment 500.00
Minimum Subsequent Investment 50.00

Dividends for UNISHSCI

Dividend Type Income
Dividend Frequency Annual
Last Dividend Net (on 2014-03-28) 0.70
Dividend Yield (ttm) 1.38

Fees & Expenses for UNISHSCI

Front Load 5.00
Back Load 5.50
Current Mgmt Fee 2.00
Redemption Fee 2.00
12b1 Fee -
Expense Ratio 2.22

Top Fund Holdings for UNISHSCI

Filing Date: 05/30/2014
Name Position Value % of Total
Sanofi 152,000 17,622,016 5.206%
Boston Scientific Corp 1,129,700 15,715,115 4.643%
BioMarin Pharmaceutical Inc 237,168 14,904,323 4.403%
Novartis AG 150,000 14,583,737 4.309%
Roche Holding AG 45,400 14,484,333 4.279%
Intercept Pharmaceuticals Inc 50,800 13,032,406 3.850%
Air Methods Corp 240,000 12,542,557 3.706%
Kyowa Hakko Kirin Co Ltd 808,064 10,611,274 3.135%
NPS Pharmaceuticals Inc 313,600 10,584,808 3.127%
Isis Pharmaceuticals Inc 332,757 10,542,296 3.115%

Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil